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Abstract
Background: The aim of this study was to investigate whether insomnia and obstructive sleep apnea (OSA) were predictors
of hospitalizations or emergency department visits during two years following the Sao Paulo Epidemiologic Sleep Study
(EPISONO) sample.
Methods and Findings: All participants (n = 1,101) who underwent a baseline evaluation between July and December 2007
were contacted in December 2009 and asked to fill out a questionnaire about body weight changes, number of hospitalizations
and visits to the emergency department. Participants lost during the follow-up period represented 3.2% (n = 35) and 7 subjects
had died. Hospitalizations were reported by 116 volunteers (10.5%) and emergency department visits were reported by 136
participants (12.4%). The average body mass index (BMI) did not vary significantly between the first and the second assessment
[26.7(95%CI:26.3–27.1) vs. 26.9(26.5–27.4) kg/m2]. After adjusting for confounders, a multiple logistic regression model revealed
that female gender [1.4(1.0–1.9)], age$40 years, insomnia diagnosed according to the DSM-IV criteria [1.6(1.0–2.6)], and apnea-
hypopnea index $15 [1.5(1.0–2.2)] were predictors of hospitalizations and/or demand for emergency services.
Conclusion: Our study of a probabilistic sample of the Sao Paulo inhabitants shows that over a period of two years, insomnia
and OSA were both associated with health impairment. Considering the high prevalence and public health burden of sleep
disorders, the consequences of untreated disease for both the individual and society are undeniable and should be addressed.
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Introduction
Sleep disorders are increasingly recognized as an important
cause of medical morbidity and mortality. Many studies have
indicated that the presence of untreated sleep disorders, especially
insomnia and obstructive sleep apnea (OSA), is associated with an
increased risk of fatal and nonfatal cardiovascular disease [1–3],
sudden death during sleep [4], death from other causes, stroke [5–
7], metabolic dysfunction [7,8], cognitive alterations [9], and
impairment in daytime activities [10]. Therefore, the presence of
untreated sleep disorders has a substantial economic and social
impact but the relationship between sleep complaints and
healthcare utilization has not been rigorously evaluated.
The purpose of the present study was to investigate whether
insomnia andOSAwere predictors of hospitalizations or emergency
department visits after a period of two years following up the sample
of the Sao Paulo Epidemiologic Sleep Study (EPISONO).
Methods
The study protocol was approved by the Research Ethics
Committee of the Universidade Federal de Sao Paulo (CEP 0593/
06), and it was registered at ClinicalTrials.gov (number:
NCT00596713). All participants read and signed a written
informed consent form.
The baseline evaluation was performed between July and
December of 2007 on volunteers enrolled in the EPISONO, a
large population-based survey conducted in the city of Sao
Paulo, Brazil. The methodological details of this study have
been described elsewhere [11]. Briefly, we used a three-stage
cluster sampling technique with unequal selection probability to
obtain a representative sample of Sao Paulo inhabitants
according to gender, age (20 to 80 years), and socio-economic
status [12]. The sample included 1,101 individuals, and it was
established to allow prevalence estimates with 3% precision
[13]. Pregnant and lactating women, people with physical or
mental impairments that prevented self-care, and people who
worked every night were excluded from the sample. Socioeco-
nomic information, medical history, medication use, and
information about sleep habits and complaints were collected
in person during home interviews. All participants were invited
to undergo an in-lab, full-night polysomnography (PSG); the
refusal rate was 5.4%.
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Two years after the baseline evaluation (December 2009), all
participants were contacted either by e-mail, telephone, or a home
visit. Interviews included a questionnaire on changes in body
weight, number and causes of hospitalizations and utilization of
any emergency services during the follow-up period.
The following predictors were evaluated during the baseline
study and were subsequently used to compare individuals who
chose to seek medical care: overweight/obesity determined by a
body mass index (BMI).25 kg/m2; diabetes that was self-reported
in response to a yes/no question; hypertension in individuals who
self-reported taking a prescribed anti-hypertensive medication or
had high blood pressure (systolic .140 mm/Hg and/or diastolic
.90 mm/Hg) measured in the sleep laboratory; symptoms of
insomnia in individuals who self-reported difficulties in initiating,
maintaining, and/or very early morning awakening at least three
times a week; insomnia as defined by the Diagnostic and Statistical
Manual of Mental Disorders (IV) in individuals reporting that the
previously mentioned symptoms had occurred in the past thirty
days and interfered ‘much’ or ‘extremely’ with daily functioning
[14]; and OSA, determined by the severity level on the apnea-
hypopnea index (AHI) divided in three groups: 1) non OSA
determined by AHI,5 plus AHI between 5 and 14.9 without
association with symptoms of excessive sleepiness, loud snoring,
fatigue, and witnessed breathing pauses during sleep; 2) mild OSA
determined by AHI between 5 and 14.9 in association with
symptoms of excessive sleepiness, loud snoring, fatigue, and
witnessed breathing pauses during sleep; 3) moderate+severe
OSA determined by AHI$15.
The statistical package used in data analysis was SPSS (version
17) for Windows. A general linear model of repeated measures was
applied to compare variations in weight and BMI. Complex
sample cross-tabulations were applied to determine the weighed
prevalence of ‘seeking medical care’ according to predictors in the
1,042 participants who had a PSG recording performed. To
generate crude odd ratios, we used multiple, unadjusted logistic
models. Because we decided to perform an exploratory analysis,
we adopted the backward Wald method to enter variables in the
fully adjusted model with all tested predictors.
Results
Of the 1,101 participants who comprised the total baseline
sample, we were able to locate 1,021 by telephone or mail. The
remaining 80 participants were visited at their homes and 45 were
located. The total number of volunteers lost represented 3.2% of
the initial sample.
Seven participants died between December 2007 and Decem-
ber 2009. The causes of death reported by their relatives were
heart disease (two), stroke (two), cancer (two) and murder during
an assault (one).
We found no significant changes in the variance of the
participants’ BMI. In 2007, weight and height were measured in
the lab, whereas in 2009, weight was self-reported by the
participants (26.7 kg/m2; 95%CI: 26.3–27.1 vs. 26.9; 26.5–27.4).
During the two-year period following EPISONO sample, a total
of 116 individuals (10.5%) were hospitalized, and 136 (12.4%)
required health care or first aid for a variety of reasons. The most
frequent causes of hospitalization and demand for emergency
services were cardiovascular events and/or high blood pressure
(27%), infectious processes or pulmonary diseases (14%), psychi-
atric problems (6%), diabetes (5%), thyroid dysfunction (4%),
cancer (3%), and other (41%) including fracture or musculoskeletal
problems, kidney and gastric conditions, and surgeries (one of
them to treat OSA). The main predictors of these events were
female gender, age $40 years, insomnia, and OSA (AHI$15).
Before adjustments were made, BMI.25 kg/m2, diabetes, and
hypertension also presented as potential factors in causing
participants to seek medical attention (Table 1). We performed
an alternative adjusted model by adding the variables non OSA,
mild OSA and moderate+severe OSA (AHI$15), along with all
other variables listed in the Table 1. In this adjusted logistic model
(data not included in the Table 1), the variable OSA did not figure
as a risk factor for hospitalizations and/or demand for emergency
services (non OSA: OR=1; mild OSA: OR=0.66 [95%CI: 0.43–
1.02], p = 0.06; moderate and severe OSA: OR=0.61 [95%CI:
0.35–1.03], p = 0.06).
Discussion
We showed that among a probabilistic sample, female gender,
age $40 years, insomnia, and OSA were significantly associated
with an increased number of hospitalizations and/or demand for
emergency services during a short EPISONO follow-up period.
Our sample included individuals from the general population and
represents the inhabitants of the city of Sa˜o Paulo between 20 and
80 years of age. In contrast to clinical populations, we evaluated
individuals who are much less likely to receive a proper diagnosis
or treatment of their sleep disorder.
A recent review by Ohayon suggests that the prevalence of
insomnia was already high two decades ago, affecting at least one-
third of the population who in most cases, did not receive a proper
diagnosis or proper treatment for their condition [15]. Studies on
the economic impact of insomnia usually discuss direct costs
related to resource consumption (i.e., consultations, exams, and
products) and indirect costs related to loss (i.e., accidents,
absenteeism, and decreased productivity). One recent study
showed that insomniacs were 6.7 times more likely to have
required medical treatment [8]. Even though severe insomnia is
directly associated with the use of healthcare services, worldwide
quantification of costs is scarce [16–19]. Nonetheless, the costs of
untreated insomnia are significantly higher than the direct costs of
its treatment [20]. Increasing awareness of the efficacy and
availability of insomnia treatment, among both patients and health
care providers, can greatly reduce its impact and total costs for
society.
The prevalence of OSA syndrome in the EPISONO cohort is
one of the highest ever found (32.9%) [21]. It is important to note
that in contrast to most studies, we define this syndrome according
to the most recent criteria described by the International
Classification of Sleep Disorders (ICSD-2) of the American
Academy of Sleep Medicine [22]. OSA is a potential predictor
of comorbidity and mortality [6,7], and also has a substantial
economic and social impact. Automobile accidents related to OSA
in 2000 are estimated to cost $16 billion [23]. Even after
controlling for confounders, leaving patients untreated generates
costs twice as high providing treatment [24]. In the US, the annual
costs of treating the medical consequences of OSA are estimated to
be $3.4 billion [25], even though almost 90% of OSA cases are
underdiagnosed [26], especially in populations at lower risk for the
disease, such as non-obese women [18], as also suggested by our
study.
A recent study showed that among US adults who participated
in the National Health and Nutrition Examination Survey, those
who reported sleep complaints also had increased healthcare
utilization. This study also suggested that sleep disorders appear to
be highly underdiagnosed [27].
Interesting enough, our study showed that moderate and
severe AHI could be a factor in association to other clinical
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conditions, which together, figured as predictor of poor health
outcome, while the AHI between 5 and 15, with or without
symptoms, was not found to be a risk factor associated with poor
health outcome. In addition, more than J of the causes of
hospitalizations and/or demand for emergency services during
the short follow-up period were linked to cardiovascular disease,
as described in previous studies evaluating OSA and even
insomnia [1–3].
Sao Paulo no doubt represents the worldwide trend of
increasing levels of obesity (22%), OSA, insomnia, hypertension,
and diabetes (among other diseases) in all metropolitan areas. It
seems logical to think that promoting good sleep would regulate
some metabolic and functional processes and might also treat
some of the other conditions described herein.
We must put forth an effort to recognize sleep disorders and also
to raise awareness of the need to educate both physicians and the
population about sleep, the diagnosis of sleep disorders, the benefit
of behavioral and psychological treatments and interventions, and
alternatives to pharmacology in individuals with chronic insomnia
and/or a comorbid psychiatric disorder. Additionally, we must
understand the potential therapeutic effects on obesity and
adherence to nasal Continuous Positive Airway Pressure or to
oral appliance treatments, which can to help us to treat OSA and
other breathing-related sleep disorders.
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Table 1. Weighted frequency (% [95%CI]) of demographic characteristics, medical history, and sleep habits and complaints of the
adult population (n = 1,042) of Sa˜o Paulo as predictors of hospitalizations or emergency department visits after a two-year follow-
up period.
No visits Visited ED/hospital Unadjusted Model** Adjusted Model***
N % (95%CI) N % (95%CI) p* OR (95%CI) p OR (95%CI) p
Gender
Men 371 79.0 (73.8–83.3) 92 21.0 (16.7–26.2) 0.187 1 1
Women 420 74.1 (96.7–78.1) 165 25.9 (21.9–30.3) 1.6 (1.2–2.2) 0.001 1.4 (1.0–1.9) 0.039
Age categories (yrs)
20–29 204 88.3 (82.3–92.5) 32 11.7 (7.5–17.7) ,0.001 1 1
30–39 204 83.9 (78.0–88.5) 44 16.1 (11.5–22.0) 1.5 (0.9–2.5) 0.121 1.6 (0.9–2.7) 0.070
40–49 194 77.0 (68.8–83.6) 60 23.0 (16.4–31.2) 2.0 (1.3–3.3) 0.004 1.9 (1.6–3.2) 0.012
50–59 112 67.5 (58.8–75.1) 53 32.5 (24.9–41.2) 3.4 (2.1–5.6) ,0.001 3.1(1.8–5.3) ,0.001
60–69 55 59.7 (45.5–72.5) 38 40.3 (27.5–54,5) 4.8 (2.7–8.4) ,0.001 4.1 (2.2–7.7) ,0.001
70–80 22 36.2 (16.7–61.6) 30 63.8 (38.4–83.3) 9.3 (4.7–18.3) ,0.001 6.6 (3.2–13.7) ,0.001
Socioeconomic Status
High 228 78.2 (72.3–83.1) 69 21.8 (16.9–27.7) 0.428 1
Mid 490 76.4 (72.1–80.2) 163 23.6 (19.8–27.9) 1.1 (0.8–1.5) 0.749
Low 73 69.2 (50.5–83.2) 25 30.8 (16.8–49.5) 1.2 (0.7–2.0) 0.565
BMI categories
#25 kg/m2 312 79.8 (74.5–84.2) 83 20.2 (15.8–25.5) 0.05 1
.25 kg/m2 439 73.8(68.0–78.8) 161 26.2 (21.2–32.0) 1.4 (1.0–1.8) 0.046
Non-diabetes 708 77.1 (73.1–80.6) 44 22.9 (19.4–26.9) 0.058 1
Diabetes 216 65.0 (50.5.77.1) 28 35.0 (22.9–49..5) 2.1 (1.3–3.4) 0.004
Non-hypertension 468 80.8 (77.0–84.1) 128 19.2 (15.9–23.0) ,0.001 1
Hypertension 264 62.4 (53.7–70.3) 116 37.6 (29.7–46.3) 2.4 (1.6–3.1) ,0.001
Non-insomnia 321 83.5 (78.9–87.2) 68 16.5 (12.8–21.1) 0.01 1 1
Insomnia complaints 360 72.2 (66.4–78.3) 143 27.2 (21.7–33.6) 1.8 (1.3–2.5) ,0.001 1.4 (1.0–2.0) 0.053
DSM-IV insomnia 110 67.9 (58.9–77.3) 46 32.1 (22.7–43.1) 1.9 (1.3–3.0) 0.002 1.6 (1.0–2.6) 0.036
AHI categories
,15 646 79.3 (75.9–82.4) 178 20.7 (17.6–24.1) 0.002 1 1
$15 106 62.1 (49.2–73.4) 66 37.9 (26.6–50.8) 2.1 (1.5–30.) ,0.001 1.5 (1.0–2.2) 0.048
ED: emergency department; BMI: body mass index; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders; AHI: apnea-hypopnea index.
*Chi-square: test of independence of rows and columns (for complex samples).
**Logistic regression.
***Backward Wald Logistic regression – Of all variables entered at the 1st step, these were the ones that comprised the final model in the 6th step.
doi:10.1371/journal.pone.0030085.t001
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